These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 15230033)
1. [The new class of drugs-- metalloprotease inhibitors -- in the treatment of heart failure]. Berezin AE Klin Med (Mosk); 2004; 82(5):7-15. PubMed ID: 15230033 [No Abstract] [Full Text] [Related]
11. Vasopeptidase inhibitors for heart failure: where do we go from here? Richards AM Eur J Heart Fail; 2003 Aug; 5(4):411-3. PubMed ID: 12921800 [No Abstract] [Full Text] [Related]
12. Vasopeptidase inhibitors: potential role in the treatment of heart failure. Trindade PT; Rouleau JL Heart Fail Monit; 2001; 2(1):2-7. PubMed ID: 12634892 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance and therapeutic application of atrial natriuretic peptides]. Hirata Y Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):112-8. PubMed ID: 1850778 [No Abstract] [Full Text] [Related]
14. Omapatrilat for the management of heart failure and hypertension. Husereau DR Issues Emerg Health Technol; 2001 Jun; (17):1-4. PubMed ID: 11776285 [TBL] [Abstract][Full Text] [Related]
15. [Omapatrilat--new drug for patients with hypertension and heart failure]. Dzielska-Olczak M Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325 [TBL] [Abstract][Full Text] [Related]
18. [Vasopeptidase inhibitors: new pharmacologic classes, new therapeutic opportunities]. Morganti A Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):829-31. PubMed ID: 12497830 [No Abstract] [Full Text] [Related]
19. Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators. Cleland JG; Swedberg K Lancet; 1998 May; 351(9116):1657-8. PubMed ID: 9620738 [No Abstract] [Full Text] [Related]